Navi
Right
 
Skip Navigation LinksHome Research report list Pharma & Healthcare Healthcare Global Hepatitis C Virus (HCV) Market DataPack - 2016 Edition
 
Social
Global Hepatitis C Virus (HCV) Market DataPack - 2016 Edition
Format : Pdf (Instant Download)
Date: 07, September 2016 | Pages: 72
Social
 
Electronic Access - Single User License
Tool
USD 450
Electronic Access - Corporate User License
Tool
USD 550
Hard Copy - Mail Delivery
Tool
USD 500
 
   
 

The Industry DataPack provides a unique mix of market information, analysis and estimates based on quantitative and qualitative research.


The market figures and industry dynamics are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace.


It presents a reliable assessment of the industry including key industry metrics, regional market analysis, market trends and growth drivers.


It also explores the competitive landscape of the respective market with focus on major players.


The DataPack serves as a must read for anyone willing to invest in this market and trying to evaluate opportunities.


Our success parameter is very simple - impact of our services on our clients' business. We provide high quality, cost effective research and analysis to support decision making processes for industry professionals. Our strength lies in the reliability of our research and on the value added analysis that we provide.


We have a team of research analysts who have mastered the skill of preparing flawless market intelligence reports to help clients maximize their productivity and return on investment. Our analysts have great expertise to assess current trends in business practices, product promotion and market competition. 

 

Types of Hepatitis C Virus (HCV)
Natural History of HCV Infection
Global HCV Market by Value (2011-2015)
HCV Genotype 1 Patients in Emerging Markets (2015)
Global Deaths Due to HCV (2010-2014)
The US HCV Market by Value (2011-2015)
The US HCV Market Dynamics (2014)
Total Estimated HCV Patients to be treated in US (2015)
Total Estimated Genotype1 Patients to be treated in the US (2015)
Estimated HCV Patients to be treated in the US (2016E–2029E)
Patients Initiating Treated with Sofosbuvir Based Regimen (2015)
HCV Patients Initiated Treatment with Sofosbuvir based Regimen by Genotype (2015)
HCV Patients Initiated Treatment with Sofosbuvir based Regimen by Fibrosis Score (2015)
HCV Patients Initiated Treatment with Sofosbuvir based Regimen by Patient Type (2015)
EU HCV Market by Value (2011-2015)
Estimated Number of Patients to be treated in EU (2016E – 2029E)
Japanese HCV Market by Value (2011-2015)
Estimated Number of Patients to be treated in Japan (2016E–2029E)
Rest of World HCV Market by Value (2011-2015)
Reimbursement Situation (2015)
Global GDP Growth (2006-2014)
Global Healthcare Expenditure (2007-2014)
Frequency of Patients Warehoused Currently by Doctors (2014)
Warehoused Patients Expected to be treated in 2015
Warehoused Patients Expected to be treated in 2016
Global Ageing Population (2006-2014)
Mix of Doctors in Survey (2014)
Frequency of New Patients Treated per Month (2014)
Newly Identified Patients per Year (2015E–2029E)
Percentage of New Diagnosed Patients (2015E – 2029E)
Global Market Share of HCV and HBV (2014)
Global Market Share of HCV and HBV (2020E)
Global Sales of Sovaldi, Harvoni and Viekira Pak (2015)
The US Market Share of Viekira and Harvoni (2014)
Factors Affecting the Growth of Viekira (2014)
Factors affecting while Prescription of Harvoni and Viekira (2014)
The US Market Share by Company (2016E)
Gilead Revenue and Net Income (2010-2014)
AbbVie Revenue and Net Income (2010-2014)
J&J’s Consumer Sales by Segment (2014)
J&J’s Pharmaceutical Sales by Segment (2014)
Global Medical Devices Sales by Segment (2014)
Johnson & Johnson Revenue and Net Income (2010-2014)
J&J’s Research & Development Expenses by Segment (2013-2014)
Bristol Myers Squibb Revenue and Net Income (2010-2014)
Bristol-Myers Revenue by Region (2014)
Global HCV Market Forecast (2014-2019E)
Different Ways of Transmission of HCV
Global HCV Prevalence by Region (2014)
Summary of Survey Population
Market Share Based on Contracted Lives
Clinical Factors Affecting Market Share of AbbVie Vs. Gilead (2014)
Cure Rates with New Direct Acting anti-Viral - DAA (2014)
Viekira Pak Pill Order
Future Regimens of Gilead, AbbVie and Merck
Dependent & Independent Variables (2011-2015)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

Types of Hepatitis C Virus (HCV)
Natural History of HCV Infection
Global HCV Market by Value (2011-2015)
HCV Genotype 1 Patients in Emerging Markets (2015)
Global Deaths Due to HCV (2010-2014)
The US HCV Market by Value (2011-2015)
The US HCV Market Dynamics (2014)
Total Estimated HCV Patients to be treated in US (2015)
Total Estimated Genotype1 Patients to be treated in the US (2015)
Estimated HCV Patients to be treated in the US (2016E–2029E)
Patients Initiating Treated with Sofosbuvir Based Regimen (2015)
HCV Patients Initiated Treatment with Sofosbuvir based Regimen by Genotype (2015)
HCV Patients Initiated Treatment with Sofosbuvir based Regimen by Fibrosis Score (2015)
HCV Patients Initiated Treatment with Sofosbuvir based Regimen by Patient Type (2015)
EU HCV Market by Value (2011-2015)
Estimated Number of Patients to be treated in EU (2016E – 2029E)
Japanese HCV Market by Value (2011-2015)
Estimated Number of Patients to be treated in Japan (2016E–2029E)
Rest of World HCV Market by Value (2011-2015)
Reimbursement Situation (2015)
Global GDP Growth (2006-2014)
Global Healthcare Expenditure (2007-2014)
Frequency of Patients Warehoused Currently by Doctors (2014)
Warehoused Patients Expected to be treated in 2015
Warehoused Patients Expected to be treated in 2016
Global Ageing Population (2006-2014)
Mix of Doctors in Survey (2014)
Frequency of New Patients Treated per Month (2014)
Newly Identified Patients per Year (2015E–2029E)
Percentage of New Diagnosed Patients (2015E – 2029E)
Global Market Share of HCV and HBV (2014)
Global Market Share of HCV and HBV (2020E)
Global Sales of Sovaldi, Harvoni and Viekira Pak (2015)
The US Market Share of Viekira and Harvoni (2014)
Factors Affecting the Growth of Viekira (2014)
Factors affecting while Prescription of Harvoni and Viekira (2014)
The US Market Share by Company (2016E)
Gilead Revenue and Net Income (2010-2014)
AbbVie Revenue and Net Income (2010-2014)
J&J’s Consumer Sales by Segment (2014)
J&J’s Pharmaceutical Sales by Segment (2014)
Global Medical Devices Sales by Segment (2014)
Johnson & Johnson Revenue and Net Income (2010-2014)
J&J’s Research & Development Expenses by Segment (2013-2014)
Bristol Myers Squibb Revenue and Net Income (2010-2014)
Bristol-Myers Revenue by Region (2014)
Global HCV Market Forecast (2014-2019E)
Different Ways of Transmission of HCV
Global HCV Prevalence by Region (2014)
Summary of Survey Population
Market Share Based on Contracted Lives
Clinical Factors Affecting Market Share of AbbVie Vs. Gilead (2014)
Cure Rates with New Direct Acting anti-Viral - DAA (2014)
Viekira Pak Pill Order
Future Regimens of Gilead, AbbVie and Merck
Dependent & Independent Variables (2011-2015)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

One can also purchase any particular sections from this report. Please send us an email to info@konceptanalytics.com with your order details.
 
 
About Us    |    PRESS RELEASES    |    RESEARCH REPORTS    |    Contact Us    |    PRIVACY POLICY    |    REFUND POLICY
@ Copyright 2014 Koncept Analytics Pvt Ltd. All Rights Reserved. Web Developed By Vision IT Consultants Pvt Ltd.